Psoriatic arthritis trials in Austria
1 of 3 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Graz, Stockerau, Vienna
- Age
- 18 years to 75 years
- People
- 1,200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693